Sarcopenic obesity: recent consensus and clinical implications in patients with chronic liver disease

Sarcopenia and obesity are two major public health concerns, particularly in the elderly population. These conditions have a significant impact on both the individual’s health and quality of life. Sarcopenia is defined as a loss of muscle mass, strength, and function physiologically present with aging, while obesity is an excessive accumulation of body fat. While these conditions are often considered separately, there is growing recognition that they frequently coexist, and may synergistically enhance one another, leading to an increased risk of various chronic diseases and mortality. Sarcopenic obesity (SO) is the term utilized to define the simultaneous occurrence of sarcopenia and obesity (1). Since recently, the lack of common diagnostic criteria for SO has made it difficult to diagnose and manage this condition effectively